This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...